SpinePoint has received FDA clearance for its Flex-Z Cervical Cage, expanding the company’s portfolio of spinal fusion technologies. The device is designed to support cervical interbody fusion procedures by providing structural stability while promoting bone growth and fusion across the disc space. Incorporating advanced implant geometry and biomaterial design, the cage aims to optimize load distribution and facilitate osseointegration. The clearance reflects continued innovation within spine surgery, where manufacturers are developing implants that balance biomechanical performance with minimally invasive surgical compatibility. As cervical fusion technologies evolve, devices such as the Flex-Z cage highlight the ongoing emphasis on improving fusion success, surgical efficiency, and patient outcomes in degenerative cervical spine conditions.